4 ± 4.1%, group B, 64.6% ± 4.8%; group
C, 65.2% ± 4.9%. In univariate analysis, SF, MELD, and serum sodium concentration at time of listing for OLT were independent factors predicting 180-day mortality (Table 3). Used as a categorical value, increasing DAPT SF was associated with an increased risk of death in patients in groups B and C (HR, 5.35, P = 0.015, and HR, 5.68, P = 0.008, respectively). Increasing MELD and decreasing serum sodium concentration as continuous variables were predictive of 180-day mortality (HR, 1.09, P = 0.017, and HR, 0.87, P < 0.001, respectively). Age, sex, and the presence of HCC at the time of listing for OLT did not predict death at 180 days. Multivariate analysis, including SF analyzed as a trichotomous variable showed increased mortality for subjects in group B (HR, 4.62; P = 0.03) with a strong trend observed in group C (HR, 3.54; P = 0.07). Serum sodium concentration when evaluated as a continuous variable was associated with a decreased risk of death (HR, 0.87; P = 0.002); in other words, patients with a
higher serum sodium concentration had a lower mortality. In univariate analysis, SF, MELD, and serum sodium concentration at time of listing for OLT were independent factors predicting 1-year mortality (Table 4). Used as a categorical value, increasing SF was associated with an increased risk of death in patients in groups B and C (HR, 5.16; P = 0.008; and HR, 5.32; AZD1208 datasheet P = 0.004, respectively).
Increasing MELD and decreasing serum sodium concentration as continuous variables were predictive of 1-year mortality (HR, 1.10; P = 0.006; and HR, 0.88; P < 0.001, respectively). Age, sex, and the presence of HCC at the time of listing for OLT did not predict death at 1 year. Multivariate analysis, including SF, serum sodium concentration, and MELD at listing showed that SF and serum sodium concentration were independent predictors of 1-year patient mortality. Serum ferritin concentration predicted increased mortality for subjects in groups B and C (HR, 4.69; P = 0.01; and HR, 3.49; P = 0.04, respectively). Serum sodium concentration evaluated as a continuous variable was associated with a decreased risk of death (HR, 0.90; P = 0.002). MCE公司 Kaplan-Meier curves (adjusted for MELD and serum sodium concentration) demonstrating significantly decreased 180-day and 1-year survival in subjects in groups B and C compared with subjects in group A are shown in Fig. 1 (P = 0.009 and P = 0.003), respectively. ROC curve analysis of 180-day and 1-year mortality was performed to assess whether the addition of SF or serum sodium concentration to MELD improved the accuracy in predicting patient survival. When used as a continuous variable, the addition of SF to MELD increased the area under the ROC curve by 7.6% (0.604-0.695, P = 0.10) and 7.5% (0.624-0.707, P = 0.10) for 180-day and 1-year patient survival, respectively (Figs. 2 and 3).